MedPath

Effect of Aamradi Hima and Shatavari Taila Matra basti on asrigdara

Phase 2/3
Not yet recruiting
Conditions
Excessive and frequent menstruation with irregular cycle. Ayurveda Condition: ASRUGDARAH/RAKTAPRADARAH,
Registration Number
CTRI/2023/07/055508
Lead Sponsor
Post Graduate Institute of Ayurveda ,Jodhpur Rajasthan
Brief Summary

This is a single group ,open label  clinical study  to evaluate the effect of *Amradi hima* and *shatavari taila matra basti* in the management of *Asrigdara* .To reduce the sign and symptoms assess from the pictorial blood loss assessment chart(Amount and Duration of bleeding),intermenstrual bleeding with or without pain  and improve the amount of  hemoglobin .*Aamradi hima* was *sheet,vata -pitta shamak,rakta stambhak ,Daha prashmak* in nature and *shatavari* roots are  phytoestrogens. menorrhagia is due to anexcess of estrogen or reduced estrogen (atrophy of endometrium) it can help in eithercase.The roots are considered as an astringent hence they reduce menstrual flowby this property. Moreover,Asparagus was found to bean effective antiulcerogenic and anti-secretory agentand thus has its role in healing of endometrium. *Basti* pacifying *vata,*restoring the disturbed *Kapha* and *Pitta* at their origin seats thus helpsin breaking pathogenesis. so we are choosing matra basti in the management of *Asrigdara.*

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
30
Inclusion Criteria
  • Excessive bleeding or prolonged bleeding (More than 7 days) or shortness of cycle (<21 days).
  • ⮚Excessive menstrual bleeding during menstruation (menstrual blood loss >80 ml in 1-7 days) having pictorial blood loss assessment chart (PBLAC) score more than 100 points for 2 consecutive cycles.
  • Along with or without Body ache (Angamarda) and Pain (Vedana) Women between the age group 14 to 50 years (married & unmarried).
  • After 3 months withdrawal of OC pills.
Exclusion Criteria
  • Patients having bleeding due to abortion.
  • Bleeding from the site other than the uterus.
  • Patients with known Coagulation disorders.
  • Patients suffering from malignancies and chronic systemic diseases like, uncontrolled diabetes (above the range of 160-200 mg/dl), uncontrolled hypertension (Systolic blood pressure >180 & diastolic blood pressure >120mm hg).
  • Patients having Hepatitis, VDRL, HIV/AIDS.
  • If a patient conceives during trial.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assess improvement of sign & symptoms according to Pictorial blood loss assessment chart60 days
Secondary Outcome Measures
NameTimeMethod
Relief in associate symptoms like pain during menses,intermenstrual bleeding60 days

Trial Locations

Locations (1)

Post Graduate Institute of Ayurved, Jodhpur, Rajasthan

🇮🇳

Jodhpur, RAJASTHAN, India

Post Graduate Institute of Ayurved, Jodhpur, Rajasthan
🇮🇳Jodhpur, RAJASTHAN, India
DrJyoti kanwar solanki
Principal investigator
8118817782
jyotikanwarsolanki123456@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.